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Body fluid balance is critical for survival and is tightly regulated 
despite changing internal and external environmental conditions.  Body 
fluid homeostasis involves osmotic, volume, and pressure factors, all of 
which are maintained within very narrow limits, called ‘set points’.  
Deviation from the set point for osmotic regulation causes compensatory 
behavioral, hormonal, and neural responses that restore body fluid 
concentration to proper levels.  The central nervous system (CNS) is 
essential in coordinating and integrating compensatory responses to 
osmotic challenges.  For example, changes in plasma osmolality are 
detected by osmoreceptors located in areas of the brain with an 
incomplete blood-brain barrier (BBB), called circumventricular organs 
(CVOs).  CVOs, in turn, project to other areas of the CNS that are involved 
in body fluid homeostasis and, thus, function in the regulation of fluid and 
electrolyte balance. 
Estrogen is a steroid hormone that is critical for reproductive 
behavior in females and also has been implicated in the control of body 
fluid balance.  Circulating estrogen levels change across the reproductive 
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cycle and, in many cases, exert effects by binding to receptors in 
peripheral tissues.  In addition, however, estrogen receptors have been 
localized to central areas, including many that are involved in body fluid 
regulation.  These observations suggest that estrogen influences body 
fluid balance.  In fact, estrogen has been shown to affect vasopressin 
release from neurosecretory neurons in the hypothalamus in response to 
increased plasma osmolality.  Estrogen also influences compensatory 
behavioral responses to body fluid challenges.  For example, estrogen 
decreases water intake stimulated by extracellular dehydration via 
interactions with the Renin-Angiotensin-Aldosterone System (RAAS). 
On the other hand, the evidence for the involvement of estrogen in 
water intake stimulated by intracellular dehydration has been less clear.  
However, recent work from our laboratory showed that estrogen treatment 
decreased the latency to begin drinking in ovariectomized rats given a 
slow, hypertonic saline infusion, but did not significantly affect the duration 
of the first drinking bout, water intake during the first bout, or the total 
volume of water consumed.  The decreased latency to begin drinking in 
estrogen-treated rats could be due to a difference in renal function as a 
result of estrogen treatment, or to a difference in the ability of the CNS to 
detect changes in plasma osmolality as a result of estrogen treatment.  
Accordingly, the goal of these studies is to determine whether the 
decreased latency to begin drinking is due to the effects of estrogen at the 
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REVIEW OF LITERATURE 
 
Survival during constantly changing internal and external 
environmental conditions requires adequate perfusion of all body tissues 
to provide sufficient fuels for cellular metabolism.  The fluid required to 
supply tissues must be delivered in appropriate volumes and pressures to 
facilitate exchange of metabolic fuels and gases, and it must contain 
electrolytes in appropriate concentrations for proper enzymatic and neural 
function.  Thus, body fluid regulation involves osmotic, volume, and 
pressure regulation, all of which are maintained within very narrow limits, 
called ‘set points’.   
Under normal conditions, plasma osmolality ranges from 289-295 
mOsmol/kg water in rats and 285-290 mOsmol/kg water in humans11.  An 
increase or decrease of as little as 1-2%17 from the set point for osmotic 
regulation results in compensatory behavioral, hormonal, and neural 
responses that restore body fluid concentration to proper levels.  For 
example, environmental conditions of extreme heat lead to excessive fluid 
loss in sweat, and thereby elevate plasma Na+, the primary electrolyte in 
body fluids.  In response, vasopressin (VP) is released from the posterior 
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pituitary, leading to urinary water retention.  At the same time, increased 
release of oxytocin (OT) from the posterior pituitary and atrial natriuretic 
peptide (ANP) from the heart promote renal excretion of Na+.  Together, 
these responses reduce or dilute plasma Na+, as does absorption of water 
ingested in response to activation of peripheral and central 
osmoreceptors.  Further increases in plasma Na+ are prevented by 
changes in activation of central neural pathways that mediate salt intake, 
as well as by suppression of aldosterone and angiotensin II (AngII), both 
of which act at central sites to stimulate salt intake28. 
 
The central nervous system and osmotic regulation:  detection of changes 
in plasma osmolality. 
The central nervous system (CNS) is critical in coordinating and 
integrating compensatory responses to osmotic challenges.  Clearly, to 
accomplish this, the CNS must be able to detect changes in plasma 
osmolality.  The brain is normally buffered from potentially harmful 
constituents circulating in the blood by the blood-brain barrier (BBB), an 
organization of non-fenestrated capillaries that, by virtue of a continuous 
epithelium with a dense arrangement of glial processes on the brain side 
of the capillary basilar membrane, prevents the movement of many 
organic compounds and ions.  Passage across the BBB is biochemically 
and locally selective3.  Lipophilic messenger molecules may diffuse 
through the lipid bilayers of the endothelial cell walls, whereas some polar 
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compounds are transported across the BBB endothelia by specific 
molecule carriers.  In general, however, transfer of most large molecules 
is possible only in specific small structures with an incomplete or “leaky” 
BBB due to fenestrated capillaries.  These structures are the 
circumventricular organs (CVOs), specialized central areas that serve as 
the functional interface between the brain and the periphery28. 
The primary CVOs include the hindbrain area postrema (AP), the 
hypothalamic subfornical organ (SFO), and the organum vasculosum of 
the lamina terminalis (OVLT).  The arrangement of capillaries and glia in 
CVOs suggest that these structures receive peripheral signals from 
molecules such as hormones involved in body fluid regulation, and from  
electrolytes that circulate throughout the bloodstream.  In other words, 
sensory CVOs serve as targets on which circulating agents act to 
influence brain function.  Consistent with this role, the OVLT, which lines 
the recessus supraopticus, is a site of osmoreception; the SFO, which is 
located dorsal and caudal to the anterior commissure, is an important 
target for circulating angiotensin II; the AP, which is located at the dorsal 
surface of the medulla oblongata and bordered ventrolaterally by the 
nucleus of the solitary tract (NTS), monitors circulating hormones, 
particularly vasopressin.  In addition to receiving circulating hormonal and 
electrolyte signals, CVOs share reciprocal neural connections with other 
brain areas.  That is, CVOs not only relay information to other central 
areas, but also receive input from other central areas.  In short, CVOs 
 6
receive peripheral input, process these signals via local (synaptic and/or 
humoral) interactions, and eventually send their integrated output into 
other areas within the brain. 
In terms of osmotic regulation, CVOs are able to “see” changes in 
plasma osmolality because of their incomplete BBB.  More specifically, 
CVOs contain electrophysiologically defined osmoreceptive cells that 
function in the regulation of fluid and electrolyte balance(see 3 for review).  
Although there is debate about the specific mechanisms for such 
osmoreceptivity, candidates include aquaporins, vanilloid receptors, and 
mechanical stretch-gated Na+ channels.  Regardless of the mechanism, 
though, the osmoreceptors that are more important for eliciting drinking 
are located in CVOs.  More specifically, increases in water intake and VP 
release, typical responses to increased body fluid osmolality, are 
attenuated by lesions of the OVLT.  Numerous other studies also have 
provided compelling evidence supporting the involvement OVLT in the 
osmotic regulation of neurohypophysial hormone release.  For example, 
anatomical studies of male rats by Bourque4 show that neurons within the 
OVLT send axonal projections into the supraoptic and paraventricular 
hypothalamic nuclei, areas containing the magnocellular neurosecretory 
cells (MNC) that release OT and VP.  Moreover, electrophysiological 
studies have shown that an acute systemic hypertonic stimulus increases 
the firing rate of OVLT neurons that project to MNC, and also enchances 
production of the nuclear protein Fos by these OVLT neurons14,15.  In 
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addition, injections of hypertonic saline directly into the OVLT in vivo 
cause an increase in the firing rate of MNC14.  However, projections from 
OVLT neurons to MNC may be excitatory or inhibitory, as evidenced by 
reports that electrical stimulation of the OVLT can provoke both excitatory 
and inhibitory responses in MNC14.  Taken together, these studies provide 
strong evidence that the OVLT is a critically important CVO in mediating 
central activation by and responses to osmotic challenges.  At present, 
however, the specific role of the OVLT in osmotically stimulated water 
intake is not completely understood. 
 
Estrogen and central estrogen receptors in osmotic regulation 
Estrogen is a steroid hormone that is well established to be critical 
for reproductive behavior in females, and also has been implicated in the 
control of body fluid balance.  Circulating estrogen levels fluctuate across 
the reproductive cycle and produce effects by binding to specific receptors 
in peripheral tissues.  Estrogen also binds to receptors in the CNS and 
produces effects that are attributable to classic steroid actions:  estrogen 
diffuses into the cell and forms a complex that is translocated to the 
nucleus where it binds to an estrogen response element, altering gene 
expression and transcription.  The receptors involved in these effects are 
of two types:  estrogen receptor α (ER- α) and estrogen receptor β (ER-β).  
It has recently become clear that estrogen not only produces slowly 
occurring genomic effects by binding to intranuclear receptors, but also 
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has more rapidly occurring nongenomic effects via actions at cell-surface 
receptors13.  For example, estrogen alters neural responses to 
neurotransmitters by affecting intracellular protein kinase pathways.  In 
addition, it has been reported by Lagrange and Mermelstein2,5 that 
estrogen receptors are coupled to K+ and Ca2+ channels. 
Estrogen is a likely candidate to influence central control of body 
fluid balance, as evidenced by the localization of estrogen receptors to 
many central areas involved in body fluid regulation25,26,29,30,31. Receptors 
for estrogen have been localized to OVLT, as well as to NTS, ventrolateral 
medulla (VLM), and parabrachial nucleus (PBN), raising the possibility that 
estrogen affects detection of changes in hormones or electrolytes that 
signal changes in fluid balance or modulates activation in central 
pathways independent of changes in the initial detection.  A recent study 
by Hartley6 showed that estrogen increased neural activation, as indicated 
by immunolabeling for the fos protein, in the supraoptic nucleus (SON) of 
ovariectomized rats after an osmotic load.  While these findings are an 
important link between estrogen enhancement of osmotically-stimulated 
VP release and central activation, they do not provide specific information 
about whether the effects are attributable to estrogen-mediated alterations 
in the detection of and/or sensitivity to the osmotic stimulus or to estrogen 
modulation of activation in central pathways, nor do they allow one to 
generalize to estrogen effects on osmotically stimulated water intake.   
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To date, studies examining the effect of estrogen on water intake in 
response to increased plasma osmolality produced by a systemic salt load 
have produced conflicting results.  Kucharczyk9 showed that water intake 
induced by 1M NaCl did not differ significantly during the various stages of 
the estrus cycle in rats.  Krause et al8 showed that there were no 
differences in the volume of water consumed by ovariectomized rats given 
a 2M NaCl injection, whether or not they were treated with estrogen.  
However, Thrasher and Fregly10 showed that chronic treatment with 
synthetic estrogen attenuates the drinking response to an IP load of 
hypertonic saline (1 M NaCl, 1% of body weight).  It seems likely that 
methodological differences contribute to the conflicting findings.  For 
example, in the study by Krause et al, the salt load was administered 
subcutaneously, whereas Thrasher and Fregly delivered a different dose 
of hypertonic saline intraperitoneally.  Moreover, Kucharczyk tested intact, 
cycling rats; Krause and colleagues tested ovariectomized rats that were 
given estrogen for two days and tested two days later; and Thrasher and 
Fregly gave intact female rats estrogen continuously via implantation with 
Silastic tubing containing estrogen for more than four months before 
testing.  However, a more important complication in these previous studies 
centers around the route of administration and the volume of the 
hypertonic saline that was administered.  Specifically, all of those studies 
employed rapid delivery of a large salt load that may have increased 
plasma osmolality well in excess of the threshold for water intake, and 
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thereby obscured subtle effects of estrogen on osmotically stimulated 
drinking. 
Recent work from our laboratory showed that the latency to begin 
drinking during a slow hypertonic saline infusion was significantly less in 
estrogen-treated ovariectomized rats compared to ovariectomized rats 
without estrogen.  There were no differences in the duration of the first 
drinking bout, in water consumed during the first bout, or in total volume of 
water consumed. The effect of estrogen to decrease the latency to 
osmotically-stimulated drinking may be due to alterations in renal function 
or to differences in the detection of changes in plasma osmolality by the 
CNS. In other words, the decreased latency to water intake could be 
attributable to differences in kidney function that lead to more rapid 
increases in plasma osmolality and/or to increases of a greater magnitude.  
Alternatively, estrogen may not affect renal function, but may alter the way 
the CNS “sees” the increase in plasma osmolality. 
 
 Goals and Objectives 
The goal of this thesis is to determine which of these possibilities 
underlies the decreased latency to water intake in estrogen-treated rats 
after a systemic salt load.  Therefore, I have conducted parallel 
experiments designed 1) to examine the effect of estrogen on plasma 
osmolality after a slow intravenous infusion of hypertonic saline and 2) to 
assess the effect of estrogen on neural activation in forebrain CVOs that 
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are associated with the detection of hyperosmolality after a slow 









Adult female Sprague-Dawley rats weighing between 225-325 
grams were used in these experiments.  Animals were individually housed 
in plastic cages and given ad libitum access to rodent chow and water 
except as noted.  Rats were kept in a temperature-controlled room (21-
25oC) on a 12:12 hour light/dark cycle with lights on at 7:00 AM.  All 
procedures were approved by the Oklahoma State University Center for 
Health Sciences Animal Care and Use Committee. 
 
Ovariectomy 
Under sodium pentobarbital anesthesia (50mg/kg body weight IP; 
Sigma-Aldrich), rats were bilaterally ovariectomized (OVX) using a ventral 




After OVX and recovery, rats were anesthetized with sodium 
pentobarbital (50mg/kg body weight) and chronic, indwelling femoral 
venous catheters consisting of PE-50 tubing fused to PE-10 tubing were 
inserted.  Tubing was filled with heparinized 0.15ml NaCl (1000 U/ml) and 
the end of the catheter was tunneled subcutaneously to exit at the back of 
the neck.  Rats were given one day to recover. 
 
Estrogen Replacement 
OVX rats with indwelling femoral venous catheters were given 
subcutaneous injections of 17-β-estradiol-3-benzoate (EB, Fisher 
Scientific; 10ug/0.1ml in sesame oil) or the oil vehicle (OIL, 0.1ml) on a 
schedule that mimics patterns of estrogen fluctuations during the estrous 
cycle.  Specifically, rats were given EB or OIL daily for two consecutive 
days and were tested two days after the second injection (i.e. on Day 4). 
Rats were weighed on both days of EB/OIL treatment and on the 
day of the test.  The percent change in body weight from the first day of 
EB/OIL replacement (Day 1) to the test day (Day 4) was calculated for 
each rat as 
100 * {[Day 4 weight (g) – Day 1 weight (g)] / Day 1 weight (g)} 
These data are presented as group means +/- SE; differences in the 
percent change in body weight between EB- and OIL-treated rats were 
analyzed using independent two-tailed t-tests. 
 
 14
Experiment 1.  Plasma Osmolality 
Previous work from our laboratory showed that OVX rats treated 
with estrogen had a shorter latency to begin drinking water when given a 
hypertonic saline infusion than did OIL treated rats.  As mentioned 
previously, one possible explanation for this observation is that estrogen 
affects renal function and leads to a larger or more rapid increase in 
plasma osmolality (pOsm).  Therefore, Experiment 1 was designed to test 
the hypothesis that EB-treated OVX rats have higher pOSM than do OIL 
treated OVX rats after hypertonic saline infusion. 
 
Procedures 
1.  NaCl Infusions.  During the two days of EB/OIL injections, OVX 
rats were adapted to testing procedures by connecting the catheters to 
tubing attached to an infusion pump.  On Day 4, catheters were connected 
to the infusion pump and rats were infused intravenously with 2.0M NaCl 
(HS) or 0.15M NaCl (ISO).  Water was not available during the infusion.  
Based on the results of our previous water intake studies, rats were 
infused with HS (n=7 OIL/HS; n=6 EB/HS) or ISO (n=6 OIL/ISO; n=6 
EB/ISO) at 35ul/min for 15 minutes.  Immediately thereafter, rats were 
deeply anesthetized (sodium pentobarbital, 0.2ml, iv) and rapidly 
decapitated for collection of trunk blood. 
2.  Plasma osmolality, hematocrit, and plasma protein 
concentration.  Aliquots of trunk blood were used for determination of 
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plasma protein concentration using a refractometer (Reichert, Depew, NY) 
and hematocrit reader (LW Scientific, Inc).  The remaining blood was 
centrifuged and plasma was collected and stored at -20oC prior to analysis 
of plasma osmolality (pOsm) using an osmometer (Vapor Pressure 
Osmometer, Wescor, Inc). 
3.  Statistics.  Data are presented as group means +/- SE.  Data 
were analyzed using Statistics (StatSoft, Tulsa, OK).  Differences in 
plasma osmolality, hematocrit, and plasma protein concentration were 
assessed with a two-factor analysis of variance (ANOVA) with hormone 
treatement (EB or OIL) and test condition (ISO or HS) as the factors.  
Significant main effects or interactions (P<0.05) were analyzed using 
Student-Newman-Keuls tests. 
 
Experiment 2.  Fos-immunoreactivity 
An alternative explanation for the decreased latency to begin water 
intake after HS infusion in EB-treated OVX rats is that estrogen 
enchances the detection of increased pOsm by the CNS.  Therefore, 
Experiment 2 was designed to test the hypothesis that neural activation in 
the forebrain CVOs of EB-treated rats given HS is greater than that in OIL-






1.  NaCl Infusion.  During the two days of EB/OIL injections, OVX 
rats were adapted to testing procedures by connecting the catheters to 
tubing attached to an infusion pump.  On Day 4, catheters were connected 
to the infusion pump and rats were infused intravenously with 2.0M NaCl 
(HS) or 0.15M NaCl (ISO).  Water was not available during the infusion.  
Again, based on the results of our previous water intake studies, rats were 
infused with HS or ISO at 35ul/min for 15 minutes. 
2.  Fos-immunoreactivity.  One hour and 15 minutes after the 15 
minute infusion, rats were deeply anesthetized with sodium pentobarbital 
(0.2ml, iv).  Blood was collected from the heart for analysis of plasma 
protein concentration, hematocrit, and pOsm. Animals were then perfused 
through the heart with ISO for exsanguination followed by 4% 
paraformaldehyde.  Brains were removed and postfixed in 4% 
paraformaldehyde overnight and then placed in a 30% sucrose solution for 
cryoprotection. 
Brains were sectioned coronally on a cryostat at 40um and Fos 
immunoreactivity (Fos-ir) was demonstrated using the avidin-biotin-
peroxidase technique as previously described7.  Briefly, free-floating 
sections were rinsed in Tris-NaCl, soaked in 0.5%H2O2 for 30 minutes, 
soaked in 10% normal goat serum (NGS) for 60 minutes, and incubated 
with the primary fos antibody (Santa Cruz SC-52, rabbit anti c-fos, diluted 
1:30,000), in 2% NGS at 4oC overnight.  Sections were rinsed and then 
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incubated in biotinylated goat anti-rabbit antibody for two hours.  Sections 
were rinsed again with 2% NGS and Tris-NaCl and soaked in an avidin- 
biotin solution (Vectastain elite A+B kit) for 90 minutes.  They were rinsed 
again with Tris-NaCl and then treated with hydrogen peroxide with 
diaminobenzidine (DAB) as the chromogen for 10-15 minutes.  
3.  Quantification of Fos-ir.  For each brain, the sections were 
ordered, mounted on gelatinized slides, and allowed to dry overnight.  The 
sections were then dehydrated in 70%, 95%, and 100% ethanol and 
xylenes before coverslipping.  The sections were examined 
microscopically using a Nikon microscope equipped with a camera and 
NIS-Elements AR 2.30 software.  Based on previous reports of the 
involvement of the OVLT in the detection of an increase in pOsm, I 
identified the OVLT as described in Paxinos and Watson27.  The number 
of Fos-positive cells was counted in 2-4 matched, representative sections 
from each rat, and the average number of Fos-positive cells in the OVLT 
was calculated for each rat (n=3 EB/HS; n=3 OIL/HS).  Another forebrain 
CVO, the subfornical organ (SFO), also was identified as described by 
Paxon and Watson27, the number of Fos-positive cells was counted in 2-4 
matched, representative sections from the SFO from each rat, and an 
average was calculated for each rat (n-3 EB/HS; n=OIL/HS). 
4.  Statistics.  Data are presented as group means +/- SE.  In this 
preliminary evaluation of neural activation in the OVLT and SFO, we 
limited our comparisons of Fos-ir in EB- and OIL- treated rats after HS 
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Table 1 shows body weight during EB and OIL replacement.  EB-treated 
rats lost body weight during the 4-day protocol, whereas OIL-treated rats gained 
body weight during that time. The percent change in body weight from Day 1 to 
Day 4 was significantly greater (p<0.001) in OIL-treated rats than in EB-treated 
rats.  These results are consistent with our previous studies(e.g. 8) and indicate 
that estrogen treatment was effective. 
 
OIL EB
Day 1 Day 4 % change Day 1 Day 4 % change
264.9 278.5 5.12 265.3 263.3 -0.72  
Table 1.  Percent change in body weight during EB and OIL replacement. 
 
 
 Plasma osmolality, hematrocrit, and plasma protein concentration after HS 
infusion 
 
Figures 1, 2, and 3 summarize the results from Experiment 1, showing the 
effect of estrogen on pOsm, hematocrit, and plasma protein concentration after 
infusion of hypertonic saline (HS) or isotonic saline (ISO).  Plasma osmolality 
(Figure 1) increased after HS infusion [F(1,21) = 56.66, p<0.001]; however, there 
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were no differences between EB and OIL-treated rats.  Plasma protein 
concentration (Figure 2) decreased after HS infusion [F(1,21) = 5.41, p<0.05]; but 
again, there were no differences between EB and OIL-treated rats.  Neither EB 
























































































Fos-ir after HS infusion 
 Figures 4 and 5 summarize the results from Experiment 2, showing the 
number of Fos-positive cells in the OVLT and the SFO in EB and OIL-treated rats 
after HS infusion.  There was no difference in the number of Fos-positive cells in 
the OVLT between EB and OIL-treated rats after HS infusion (Figure 4), nor did 
the number of Fos-positive cells in the SFO differ between EB- and OIL- treated 





















































In these initial evaluations of neural activation, the numbers of rats infused with 
ISO were insufficient to legitimately include the data in statistical comparisons; 
therefore, we limited our analyses to EB- and OIL-treated rats infused with HS.  
However, several points are worth noting.  First, after ISO infusion, the number of 
Fos-positive cells did not appear to differ between EB- and OIL- treated rats in 
either the OVLT (46 vs 51, respectively) or the SFO (3 vs 3, respectively).  
Second, comparison of these numbers with the data shown in Figures 5 and 6 
suggest that HS infusion did not increase the number of Fos-positive cells in the 
SFO or in the OVLT in either group. 
 Figure 6, which shows representative sections from the OVLT of rats 
infused with ISO and HS, illustrates the lack of effect of HS infusion on Fos-ir in 
the OVLT.  In contrast, Fos-ir increased substantially in the SON after HS, as 
illustrated by the representative sections from the SON of rats infused with ISO 
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and HS shown in Figure 7.  There was no effect of estrogen treatment on pOsm 
after HS infusion (OIL:  287.5 +/- 1.8 mOsm/L, EB:  286.3 +/- 2.0 mOsm/L), nor 









Figure 6.  Sections from OVLT of rats infused with ISO(left) and HS(right)
ot
Figure 7.   Sections of SON from rats infused with ISO (left) and HS (right).  







 Previous studies from our laboratory showed that OVX rats treated with 
estrogen had a shorter latency to begin drinking water when given a hypertonic 
saline infusion compared to OIL-treated rats.  These findings parallel the results 
of studies showing that estrogen increases osmotically-stimulated VP release 
and suggest the involvement of estrogen actions in the CNS in mediating these 
effects.  However, the decreased latency to begin drinking in EB- treated rats 
could instead be due to differences in the function of the kidney.  In these 
experiments, I sought to determine whether the decreased latency to water 
intake in EB treated rats after a systemic salt load is attributable to differences in 
renal function that lead to larger and/or more rapid increases in plasma 
osmolality or to alterations in the detection of the salt load by the CNS. 
Experiment 1 tested the hypothesis that EB-treated OVX rats have higher 
pOsm than do OIL-treated OVX rats after HS infusion.  The results showed no 
differences in pOsm between EB-treated OVX rats and OIL-treated OVX rats.  
Moreover, there were no estrogen effects on plasma volume, as indicated by 
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hematocrit and plasma protein concentration, that could indirectly affect 
water intake.  These findings suggest that even though the kidneys express both 
the classic ER-α and the more recently discovered ER-β18, renal function in 
response to an intravenous infusion of hypertonic saline is not affected by 
estrogen.  In other words, estrogen enhances the behavioral effects of 
hyperosmolality without differentially affecting plasma osmolality.  The possibility 
cannot be ruled out that our methods were insufficiently sensitive to detect 
differences in plasma osmolality that, while slight, may have contributed to the 
difference in the latency to begin drinking.  Nonetheless, we did not observe 
statistically significant differences in plasma osmolality between estrogen and 
OIL-treated rats.  Thus, it is feasible that estrogen-induced differences in the 
behavioral response to an osmotic stimulus are attributable to estrogen effects 
on receptors within the CNS25,26,29,30,31 that alter the detection of hyperosmolality. 
Changes in plasma osmolality are detected by osmoreceptors in forebrain 
CVOs and Simon’s3 work indicates that the osmoreceptors important for eliciting 
drinking are located in the OVLT.  Moreover, estrogen receptors are located in 
CVOs, including the OVLT25,26,29,30,31.  Accordingly, Experiment 2 tested the 
hypothesis that neural activation in the forebrain CVOs, and in particular the 
OVLT, of EB- treated rats given hypertonic saline is greater than in OIL-treated 
rats.  The results showed no differences, as indicated by Fos-ir, in the OVLT or in 
the SFO between EB- and OIL- treated OVX rats after HS infusion.  These 
findings suggest that the enhanced behavioral effects are not attributable to 
estrogen-mediated alterations in the detection of osmotic stimuli by forebrain 
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CVOs.  In other words, estrogen does not increase the sensitivity of forebrain 
CVOs to increased plasma osmolality.  Importantly, HS infusion increased neural 
activation in other CNS areas such as the SON.  Thus, the absence of a clear 
effect of HS infusion on fos-ir in SFO and OVLT was not because the stimulus 
was insufficient to increase neural activity. 
The findings from the present study using Fos-ir as a marker of neural 
activation are surprising.  There is some evidence that the SFO is activated by 
osmotic stimuli(e.g.15), which clearly was not the case in the present study; 
however, most evidence points to the OVLT in the central detection of 
hyperosmolality(e.g.15). Nonetheless, despite those findings, and despite findings 
by Simon and others3 of osmoreceptors for drinking in the OVLT, we observed 
no differences in Fos-ir in the OVLT between EB- and OIL-treated rats.  It is 
possible that HS infusion differentially inhibits neural activation within a specific 
subpopulation of neurons.  If that is the case, given that fos expression does not 
increase with neural inhibition, use of the fos technique would not allow us to 
detect group differences in cells in the OVLT that are inhibited by an osmotic 
stimulus.  However, although Bourque14 showed inhibitory responses in central 
areas that receive projections from OVLT neurons after electrical stimulation of 
the OVLT, to my knowledge, there are no reports that OVLT neurons are 
themselves inhibited by increased plasma osmolality.  In contrast, there are 
many reports of increased neural activation in the OVLT in response to 
hyperosmolality(e.g.15).  Thus, it seems unlikely that the lack of effect of estrogen 
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on neural activity in the OVLT (or the SFO) is attributable to a methodological 
limitation that precludes the detection of differences in neural inhibition. 
Although the results from the present studies do not provide a conclusive 
explanation for the enhanced behavioral effects of estrogen, they do provide 
directions for further investigations.  For example, it is possible that estrogen 
enhances detection of increased osmolality by osmoreceptors in a CVO in the 
hindbrain, the area postrema.  The area postrema is known to be important in 
osmoregulation, as area postrema lesions in adult male rats produce a 
spontaneous intake of NaCl up to as much as 108ml/day24.  Moreover, Simonian 
and Herbison found that the rat area postrema contain immunoreactive estrogen 
receptors (ER-ir)25.  In fact, Scott and colleagues found that the area postrema in 
sheep contain the largest and most densely stained population of ER-ir cells in 
the brainstem26.  Accordingly, additional studies of Fos-ir may be conducted to 
determine whether estrogen affects osmotically-stimulated neural activation in 
the area postrema. 
An alternative possibility is that estrogen enhances behavioral responses 
by affecting osmoreceptors located in the periphery and, more specifically, in the 
hepatic portal venous system.  In fact, Adachi et al16 demonstrated that the 
hepatic vagus involves two different types of osmosensitive afferent fibers using 
electrophysiological and behavioral methods.  Thus, one strategy to address the 
question of whether estrogen influences peripheral osmoreceptors is to record 
electrophysiological activity from their neural afferents to the CNS in EB- and 
OIL- treated OVX rats during HS infusion. 
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A different approach involves examination of the afferent terminal sites of 
the peripheral osmoreceptors within the CNS.  These osmoreceptors send neural 
input to the NTS19 which, in turn, projects to other CNS areas, including 
vasopressin neurons in the hypothalamus32.  In fact, Kahrilas and Rogers19 
showed that the NTS is responsive to changes of 1% or less in portal blood Na+ 
concentration.  Thus, activity of neurons in vagal terminal sites in the NTS may 
reflect estrogen-induced changes in the sensitivity of peripheral osmoreceptors.  
Accordingly, an additional study might examine differences in responsiveness of 
the NTS to increased plasma osmolality after estrogen treatment using Fos-ir.   
Finally, it is possible that estrogen effects could be due to modulation of 
activation in central pathways independent of changes in the initial detection by 
osmoreceptors in CVOs or the periphery.  Studies with c-fos and other immediate 
early genes7 have provided evidence that intracerebroventricular (ICV) injections 
of carbachol induce activity in central structures associated with water intake, 
including the OVLT and hypothalamus.  In fact, there is considerable evidence to 
suggest a cholinergic link in the neural control of vasopressin release.  
Intracarotid administration of acetylcholine (Ach) increases the electrical firing 
rate of MNC in the SON, as well as the output of vasopressin in hydrated rats22.  
Moreover, Iitake et al21 demonstrated that acetylcholine and its agonists can act 
centrally to increase the activity of vasopressinergic MNC, likely via cholinergic 
receptors on MNC in the SON and PVN22.  Finally, Gosbee and Lederis23 
demonstrated increased vasopressin release in rats after direct application of 5-
20ng of carbachol to the neural lobe of the pituitary. 
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In addition, numerous studies of water intake by male rats have used 
intracerbroventricular (ICV) injections of carbachol33, a procedure commonly 
thought to mimic activation of central pathways involved in osmotically-stimulated 
drinking28,33.  Given estrogen effects on vasopressin release in response to 
increased osmolality6,11, estrogen-induced changes in central cholinergic 
pathways seem a likely candidate for the reduced latency to water intake by EB-
treated rats in response to HS infusion.  Observations by Kisley et al20 that water 
intake induced by ICV injection of carbachol was not affected by estrogen 
treatment would seem to argue against this idea.  However, the aim of those 
investigators was to elicit water intake comparable to that produced by ICV 
administration of angiotensin II, which stimulates less water intake by estrogen-
treated rats.  Consequently, they used only a single, large dose (365.2 ng) of 
carbachol, which may have been well above the threshold for water intake and 
therefore produced maximal drinking regardless of the presence of estrogen.  
Accordingly, an additional study using a dose-response analysis of water intake 
with ICV carbachol might reveal effects of estrogen.  For example, findings that 
carbachol produces water intake at lower doses in EB-treated rats would support 
the idea that estrogen modulates activity in central pathways involved in 
osmotically-stimulated drinking. 
In summary, these experiments attempted to determine the mechanism 
that underlies the decreased latency to water intake in estrogen-treated rats after 
a systemic salt load.  The results of Experiment 1 suggest that the decreased 
latency to water intake is not attributable to differences in renal function that lead 
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to more rapid increases in plasma osmolality and/or to increases of a greater 
magnitude.  This finding led to the alternative hypothesis that estrogen alters the 
detection of the increase in plasma osmolality by the CNS, in particular, by 
forebrain CVOs.  The results of Experiment 2 rule out estrogen-mediated 
changes in detection of the salt load by the SFO.  Moreover, it seems unlikely 
that estrogen alters neural activation in the OVLT in response to increased 
osmolality, though it will be necessary to increase the number of animals in each 
group to make this determination conclusively. 
Nonetheless, these results, in conjunction with previous studies, do allow 
conclusions to be drawn.  Specifically, estrogen reduces the latency to drinking in 
response to a systemic salt load, but this effect does not appear to be the result 
of changes in renal function or of estrogen actions of forebrain CVOs.  Rather, 
estrogen may influence osmotically-stimulated water intake by altering the 
sensitivity of hepatic osmoreceptors or of osmoreceptors in the hindbrain CVO, 
the AP.  An alternative explanation is that estrogen changes neural activity in 
central pathways independent of changes in the detection of hyperosmolality.  
Clearly, additional studies will be necessary to determine which of these 
possibilities accounts for estrogen effects on water intake in response to 
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